Page 23 - Read Online

Page 6 of 7 Veilleux et al. Mini-invasive Surg 2020;4:4 I http://dx.doi.org/10.20517/2574-1225.2020.01

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. US Centers for Disease Control and Prevention. Diabetes statistics. Available from: https://www.cdc.gov/chronicdisease/resources/
publications/aag/diabetes.htm [Last accessed on 17 Jan 2020]
2. International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: International Diabetes Federation, 2019. Available
from: http://www.diabetesatlas.org [Last accessed on 17 Jan 2020]
3. World Health Organization - Diabetes. Available from: https://www.who.int/health-topics/diabetes [Last accessed on 17 Jan 2020]
4. Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Surg Obes Relat Dis
2011;7:433-47.
5. Reusch JE, Manson JE. Management of type 2 diabetes in 2017: getting to goal. JAMA 2017;317:1015-6.
6. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year
outcomes. N Engl J Med 2017;376:641-51.
7. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, et al. Bariatric-metabolic surgery versus conventional medical treatment in
obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015;386:964-73.
8. Brito JP, Montori VM, Davis AM. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international
diabetes organizations. JAMA 2017;317:635-6.
9. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KGMM, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes.
Diabetes Care 2016;39:861-877.
10. Aminian A. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve
gastrectomy. Surg Obes Relat Dis 2020. Epub ahead of print [DOI: https://doi.org/10.1016/j.soard.2019.11.013]
11. Arterburn DE, Bogart A, Sherwood NE, Sidney S, Coleman KJ, et al. A multisite study of long-term remission and relapse of type 2
diabetes mellitus following gastric bypass. Obes Surg 2013;23:93-102.
12. de Oliveira VLP, Martins GP, Mottin CC, Rizzolli J, Friedman R. Predictors of long-term remission and relapse of type 2 diabetes
mellitus following gastric bypass in severely obese patients. Obes Surg 2018;28:195-203.
13. Viscido G, Gorodner V, Signorini FJ, Biasoni AC, Navarro L. Obese patients with type 2 diabetes: outcomes after laparoscopic sleeve
gastrectomy. J Laparoendosc Adv Surg Tech A 2019;29:655-62.
14. Sánchez-Pernaute A, Rubio MÁ, Cabrerizo L, Ramos-Levi A, Torres A. Single-anastomosis duodenoileal bypass with sleeve gastrectomy
(SADI-S) for obese diabetic patients. Surg Obes Relat Dis 2015;11:1092-8.
15. Salminen P, Helmiö M, Ovaska J, Juuti A, Leivonen M, et al. Effect of laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y
gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA
2018;319:241-54.
16. Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, et al. Effect of laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y
gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA 2018;319:255-65.
17. Ruiz-Tovar J, Carbajo MA, Jimenez JM, Castro MJ, Gonzalez G, et al. Long-term follow-up after sleeve gastrectomy versus Roux-
en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of
comorbidities. Surg Endosc 2019;33:401-10.
18. Hofsø D, Fatima F, Borgeraas H, Birkeland KI, Gulseth HL, et al. Gastric bypass versus sleeve gastrectomy in patients with type 2
diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol 2019;7:912-24.
19. Aminian A, Brethauer SA, Andalib A, Nowacki AS, Jimenez A, et al. Individualized metabolic surgery score: procedure selection based
on diabetes severity. Ann Surg 2017;266:650-7.
20. Haskins IN, Corcelles R, Froylich D, Boules M, Hag A, et al. Primary inadequate weight loss after roux-en-y gastric bypass is not
associated with poor cardiovascular or metabolic outcomes: experience from a single institution. Obes Surg 2017;27:676-80.
21. Aminian A, Brethauer SA, Andalib A, Punchai S, Mackey J, et al. Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects
of sleeve gastrectomy in patients with type 2 diabetes. Ann Surg 2016;264:674-81.
22. Aleassa EM, Hassan M, Hayes K, Brethauer SA, Schauer PR, et al. Effect of revisional bariatric surgery on type 2 diabetes mellitus. Surg
Endosc 2019;33:2642-8.
23. Yan J, Cohen R, Aminian A. Reoperative bariatric surgery for treatment of type 2 diabetes mellitus. Surg Obes Relat Dis 2017;13:1412-21.
24. Dardamanis D, Navez J, Coubeau L, Navez B. A retrospective comparative study of primary versus revisional Roux-en-Y gastric bypass:
long-term results. Obes Surg 2018;28:2457-64.
25. Dijkhorst PJ, Boerboom AB, Janssen IMC, Swank DJ, Wiezer RMJ, et al. Failed sleeve gastrectomy: single anastomosis duodenoileal
bypass or Roux-en-Y gastric bypass? A multicenter cohort study. Obes Surg 2018;28:3834-42.
26. Casillas RA, Um SS, Zelada Getty JL, Sachs S, Kim BB. Revision of primary sleeve gastrectomy to Roux-en-Y gastric bypass:
indications and outcomes from a high-volume center. Surg Obes Relat Dis 2016;12:1817-25.